medindexer
Industry News · Live

What's moving the medical supply market.

Curated from medtech publications. Product launches, FDA clearances, M&A, technology shifts — rewritten as short briefs, linked back to the source. Filter by theme below.

Live
Stories
0
Sources
0
Updated
0hours ago
Filter:AllTechnologyNew productsRegulationMarket
Feed · market
§001MarketOctober 22, 2026

Alcon Expands Its Cell Therapy Ambitions With $550M Neurotech Pharma Acquisition

Alcon acquired Neurotech Pharmaceuticals for $550 million, adding the rare vision disorder cell therapy Encelto and its underlying platform technology to its portfolio. The deal follows Alcon's majority stake investment in Aurion Biotech last year, which is developing a corneal cell therapy. The acquisitions signal Alcon's strategic pivot toward cell therapy as a growth area within ophthalmology.

Source · MedCity NewsRead brief
§002MarketOctober 22, 2026

EQT to buy diagnostics player Qiagen for €9.6bn

EQT Partners agreed to acquire Qiagen, a diagnostics equipment and consumables manufacturer, for €9.6 billion. The transaction marks a significant consolidation in the in vitro diagnostics sector and follows sustained private-equity interest in the company.

Source · Medical Device NetworkRead brief
§003MarketOctober 21, 2026

Intuitive’s shares fall 8% after tempering 2026 procedural growth outlook

Intuitive Surgical revised its 2026 procedural growth guidance downward to a 14–15% midpoint, from a prior range of 13.5–15.5%, triggering an 8% decline in share price. The adjustment signals softer near-term demand expectations for the robotic surgery platform amid broader market conditions.

Source · Medical Device NetworkRead brief
§005MarketOctober 16, 2026

Sirona Medical reels in $40m for cloud-based radiology platform scaleup

Sirona Medical closed a $40 million Series D funding round led by Avidity Partners to scale its cloud-based radiology platform. The company said the capital will extend its operating runway indefinitely as it expands its software offering for radiology workflows.

Source · Medical Device NetworkRead brief
§006MarketOctober 16, 2026

Vivos to buy 50% stake in SOD Sciences’ pseudohypoxia test

Vivos Therapeutics has agreed to acquire an 11% fully diluted equity stake in SOD Sciences and a 50% co-ownership interest in SOD Sciences' pseudohypoxia early-warning diagnostic test. The investment represents a partnership to develop and commercialize the diagnostic technology.

Source · Medical Device NetworkRead brief
§007MarketOctober 15, 2026

Labcorp outlays up to $872m to acquire BioReference’s laboratory assets

Labcorp agreed to acquire BioReference's laboratory assets for up to $872 million. The transaction is intended to expand Labcorp's laboratory service capacity and accessibility. BioReference operates a network of clinical laboratory facilities serving patients and providers across multiple regions.

Source · Medical Device NetworkRead brief
§008MarketOctober 14, 2026

Healthleap Raises $38M to Expand AI Screening for Overlooked Conditions in Hospitalized Patients

Healthleap, a clinical AI platform integrated with electronic health records to screen hospitalized patients for undiagnosed conditions, raised $38 million in funding. The capital will support expansion of the platform's ability to identify at-risk patients earlier in hospital care. Healthleap operates within existing EHR systems to flag potential missed diagnoses.

Source · MedCity NewsRead brief
§009MarketOctober 14, 2026

Agilent acquires Proscia in deal worth up to $270m

Agilent Technologies has agreed to acquire Proscia for up to $270 million, with closing expected in fiscal 2027. The deal follows Agilent's $950 million purchase of Biocare Medical in March 2026, continuing the company's expansion in pathology and digital diagnostics.

Source · Medical Device NetworkRead brief
§010MarketOctober 13, 2026

Abram snags $8.3M US DoD contract to advance blood coagulation diagnostic

Abram secured an $8.3 million US Department of Defense contract to advance its blood coagulation diagnostic technology. The award follows the company's $10.75 million financing round completed in February and supports progress toward an FDA filing for the diagnostic device.

Source · Medical Device NetworkRead brief
§011MarketOctober 13, 2026

Steris outlays $2.1bn to acquire Xodus Medical

Steris has acquired Xodus Medical for $2.1 billion, adding the company's surgical safety device portfolio—including the Pink Pad—to Steris' existing lineup. The deal expands Steris' offerings in the operating room safety segment.

Source · Medical Device NetworkRead brief
§012MarketOctober 13, 2026

Hiossen and GuidedSMILE collaborate on dental implant workflows

Hiossen Implants and GuidedSMILE announced a strategic partnership to expand access to guided full-arch implant procedures across North America. The collaboration combines Hiossen's implant systems with GuidedSMILE's digital planning and surgical guidance technology to streamline implant workflows for dental professionals.

Source · Medical Device NetworkRead brief
§013MarketOctober 12, 2026

Stryker invests $400m into CMR Surgical; secures future buyout option

Stryker Corporation has invested $400 million in CMR Surgical, a UK-based developer of robotic surgical systems for soft tissue procedures, and secured an option to acquire the company in the future. The investment provides Stryker access to the robotic-assisted surgery market and establishes a path toward potential full ownership of CMR Surgical's technology platform.

Source · Medical Device NetworkRead brief
§014MarketOctober 12, 2026

Scarlet nabs $50m to grow AI-native medtech certification platform

Scarlet, a software certification platform for medical technology, raised $50 million in funding to expand its AI-native certification service across US and Asia-Pacific markets. The company provides certification services for medtech vendors, helping them navigate regulatory and compliance requirements.

Source · Medical Device NetworkRead brief
§015MarketOctober 12, 2026

Ascensia partners with Sava to commercialise wearable microsensor

Ascensia Diabetes Care has entered a commercial and financing agreement with Sava Technologies to distribute Sava's wearable glucose microsensor. The partnership combines Ascensia's market presence in diabetes management with Sava's sensor technology, expanding the continuous glucose monitoring landscape.

Source · Medical Device NetworkRead brief
§016MarketOctober 9, 2026

MMI pockets $125m to back its robotic microsurgery’s market growth

MMI secured $125 million in Series D funding to expand commercial deployment of its Symani Surgical System, a robotic platform for microsurgery. The capital will support market growth and additional research into the technology, signaling investor confidence in the robotic microsurgery segment.

Source · Medical Device NetworkRead brief
§017MarketOctober 9, 2026

SurGenTec signs licence deal with Allevion for Vantage

SurGenTec has secured an exclusive licence agreement with Allevion Medical to acquire rights to the Vantage spinal decompression system. The deal expands SurGenTec's portfolio in the minimally invasive spine surgery segment.

Source · Medical Device NetworkRead brief
§018MarketOctober 8, 2026

Startup Arboretum Sprouts, Bringing a Precision Medicine Approach to Common Diseases

Arboretum LifeSciences, a diagnostics and drug development startup, launched with $30 million in Series A funding. The company combines genetic testing with data analytics to identify disease patterns and inform drug development partnerships with major pharmaceutical firms and spawn new biotech ventures targeting common diseases.

Source · MedCity NewsRead brief
§019MarketOctober 7, 2026

Zenflow raises $52m for BPH implant and inks US distribution pact with Cook Medical

Zenflow raised $52 million in funding and signed a US distribution agreement with Cook Medical for its Spring implant, a device cleared by the FDA in December 2025 to treat benign prostatic hyperplasia symptoms. The funding and partnership expand commercial availability of the urology-focused implant in the US market.

Source · Medical Device NetworkRead brief
§020MarketOctober 7, 2026

From Distributor to Disruptor: Amazon’s Healthcare Flex

Amazon is expanding its healthcare footprint beyond pharmacy and clinic acquisitions, positioning itself to reshape pharmaceutical distribution and the broader healthcare supply chain. The move signals a strategic shift toward vertical integration and control over the commercialization pathway for drugs and medical products, potentially disrupting traditional distributor relationships.

Source · MedCity NewsRead brief
§021MarketOctober 7, 2026

OXOS Medical wins $24m BARDA contract for next-gen portable x-ray system

OXOS Medical secured a $24.4 million contract from the Biomedical Advanced Research and Development Authority (BARDA) to develop a next-generation portable X-ray system. OXOS will match the federal contribution, bringing total project value to $48.8 million. The partnership supports advancement of field-deployable imaging technology for emergency and remote medical settings.

Source · Medical Device NetworkRead brief
§022MarketOctober 7, 2026

Cambridge Heartwear receives $243m tender for HeartSense wearable

The UK NHS Supply Chain awarded a £243.7 million tender to Cambridge Heartwear to supply its HeartSense cardiac monitoring wearable. The contract represents a significant procurement win for the vendor's remote patient monitoring technology.

Source · Medical Device NetworkRead brief
§023MarketOctober 6, 2026

CellCarta, Waters Corporation collaborate on companion diagnostics

CellCarta and Waters Corporation have formed a strategic partnership to develop companion diagnostics (CDx) and next-generation flow cytometry solutions for pharmaceutical and biotechnology customers. The collaboration combines CellCarta's diagnostic capabilities with Waters' analytical instrumentation expertise to advance CDx platforms and flow cytometry technology.

Source · Medical Device NetworkRead brief
§024MarketOctober 5, 2026

GE HealthCare agrees to acquire SOFIE Biosciences in $945m deal

GE HealthCare has agreed to acquire SOFIE Biosciences, a PET radiopharmaceuticals contract manufacturer owned by Trilantic North America, for $945 million in a cash transaction expected to close in the first half of 2027. The deal expands GE HealthCare's radiopharmaceutical manufacturing and distribution capabilities.

Source · Medical Device NetworkRead brief
§025MarketOctober 5, 2026

Averly Health launches in UK to advance cardiometabolic care

Averly Health has launched operations in the UK to expand its cardiometabolic care platform. The move targets conditions including obesity and type 2 diabetes, representing a geographic expansion of the company's digital health offering to a new market.

Source · Medical Device NetworkRead brief
§026MarketOctober 2, 2026

Parakeet Health Secures $10M for Conversational Agentic Platform

Parakeet Health raised $10 million in Series A funding led by Canvas Ventures to develop a conversational agentic platform. The round included participation from Blank Space Ventures, StoryHouse Ventures, and HMC INQ. The platform targets healthcare organizations seeking AI-driven automation for administrative and clinical workflows.

Source · MedCity NewsRead brief
§027MarketOctober 1, 2026

Siemens Healthineers partners with Truvian to advance blood test platform

Siemens Healthineers has partnered with Truvian to advance the company's blood test platform. The alliance includes plans to develop and commercialize future diagnostic solutions, expanding both firms' capabilities in in vitro diagnostics.

Source · Medical Device NetworkRead brief
§028MarketOctober 1, 2026

Inogen sharpens business focus with $25m oxygen rental unit divestment

Inogen divested its oxygen rental unit for $25 million, citing declining revenues in that segment. The sale reflects the company's strategic shift to focus on core business lines as the rental business faced headwinds.

Source · Medical Device NetworkRead brief
§029MarketSeptember 29, 2026

Tiny Health Secures $33M to Expand Microbiome Testing

Tiny Health raised $33M in Series B funding led by B Capital to expand its microbiome testing offerings. The round included participation from nine venture firms including Spero Ventures and The Venture City. Tiny Health provides microbiome analysis services, typically used for pediatric and family health assessment.

Source · MedCity NewsRead brief
§030MarketSeptember 29, 2026

Eden Radioisotopes gains support from New Mexico for $1.4bn medical facility

Eden Radioisotopes has secured state support from New Mexico for a $1.4 billion medical isotope manufacturing facility. The backing enables expansion of domestic radioisotope production capacity, a key input for diagnostic imaging and nuclear medicine applications used by hospitals and imaging centers.

Source · Medical Device NetworkRead brief
§031MarketSeptember 28, 2026

Firefly to offer NeuroSigma’s non-drug ADHD device to clinicians

Firefly Neuroscience and NeuroSigma announced a partnership to distribute NeuroSigma's Monarch eTNS System, a non-pharmacological device for pediatric ADHD, to clinicians. The Monarch uses transcranial neurostimulation technology and represents a vendor collaboration to expand market reach for the cleared device.

Source · Medical Device NetworkRead brief
§032MarketSeptember 28, 2026

Accuray partners with Samsung NeuroLogica on CyberKnife imaging

Accuray announced a partnership with Samsung NeuroLogica to integrate advanced volumetric imaging capabilities into its CyberKnife robotic radiosurgery platform. The collaboration aims to enhance imaging performance for the radiation therapy system used in oncology and neurosurgery procedures.

Source · Medical Device NetworkRead brief
§033MarketSeptember 24, 2026

Anaconda Biomed raises $56m for catheter portfolio’s advance

Anaconda Biomed secured $56 million in funding to advance its catheter portfolio and support clinical development, including completion of a pivotal IDE study. The capital will accelerate the company's pipeline toward regulatory approval and commercialization.

Source · Medical Device NetworkRead brief
§034MarketSeptember 23, 2026

Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device

Teal Health raised $22 million in Series A funding for an at-home HPV cervical cancer screening device. The round was led by .406 Ventures with participation from Emerson Collective, Forerunner, Serena Ventures, and MPower Partners. The device addresses a gap in accessible cervical cancer screening by enabling testing outside traditional clinical settings.

Source · MedCity NewsRead brief
§035MarketSeptember 23, 2026

Teal Health raises $22m for at-home HPV cervical cancer screening test

Teal Health raised $22 million to expand its at-home HPV cervical cancer screening test ahead of anticipated changes to federal insurance guidelines for cervical cancer screening. The funding will support broader distribution of the test.

Source · Medical Device NetworkRead brief
§036MarketSeptember 23, 2026

QC Healthcare and Sanguina collaborate for AI blood health tools

QC Healthcare partnered with Sanguina to integrate AI-based blood health technologies into its digital healthcare platforms across the US. The collaboration combines Sanguina's blood analysis capabilities with QC Healthcare's platform infrastructure to expand AI-driven diagnostic offerings.

Source · Medical Device NetworkRead brief
§037MarketSeptember 22, 2026

Dialybrid raises $17m to advance Silkothane device

Dialybrid closed a €15 million Series A funding round to advance development of its Silkothane arteriovenous graft for hemodialysis vascular access. The capital will support the progression of the device intended to improve outcomes in dialysis patients requiring long-term access.

Source · Medical Device NetworkRead brief
§038MarketSeptember 21, 2026

CardiaCare secures seed extension funding for AFib clinical studies

CardiaCare closed an oversubscribed seed extension funding round to support clinical pilot studies of its wearable cardiac arrhythmia monitoring technology, including atrial fibrillation detection.

Source · Medical Device NetworkRead brief
§039MarketSeptember 18, 2026

Ayble Health Secures $16M for Virtual Digestive Health Clinic

Ayble Health raised $16 million in Series A funding led by Neon to expand its virtual digestive health clinic platform. The round included participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, and Accomplice. Ayble operates a telehealth service focused on gastrointestinal conditions and management.

Source · MedCity NewsRead brief
§040MarketSeptember 18, 2026

FIZE Medical secures $20m funding to advance FIZE Optima system

FIZE Medical closed the first tranche of a $20 million Series B funding round to accelerate development of its FIZE Optima platform. The capital will support the next-generation system's advancement, though specific technical details and product applications were not disclosed in the announcement.

Source · Medical Device NetworkRead brief
Archive

222 older market stories available.

View archive